As reported by The Wall Street Journal, health-products giant Johnson & Johnson has announced that it will discontinue the sale of its talc-containing Johnson’s Baby Powder in the U.S. and Canada, citing lowered sales in the wake of widespread litigation over alleged links between the powder and ovarian cancer in women who used the product for years. [Read more…]
FDA mandates halt to distribution of ranitidine (Zantac) due to potentially carcinogenic contamination
After previously warning consumers and doctors last September that it had found measurable amounts of the carcinogen NDMA (N-notrisodimethylamine) in samples of the widely-used heartburn medication Zantac, the U.S. Food and Drug Administration has now ordered manufacturers to immediately stop distributing all versions of the drug over new concerns that small amounts of the poison can increase in the drug when it is stored above room temperature. [Read more…]
Each year, around 650,000 women in the United States undergo hysterectomies. The U.S. Food and Drug Administration (FDA) estimates that one in 350 women are potentially at risk for the spread of undiagnosed cancers while undergoing a hysterectomy or other type of uterine surgery using a laparoscopic power morcellator tool. It is estimated that the 300 lawsuits that have been filed will only increase in number as more women become aware of the reported connections between morcellator use and the internal spread of undiagnosed uterine cancer.
The Judicial Panel on Multidistrict Litigation has consolidated over a dozen laparoscopic power morcellator injury and wrongful death cases filed in federal court for pre-trial discovery before Judge Kathryn H. Vratil in MDL No. 2652 in the District of Kansas (In Re: Ethicon, Inc., Power Morcellator Products Liability Litigation, MDL No. 2652).